Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,075
Total Claims
$1.3M
Drug Cost
747
Beneficiaries
$1,741
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+38%
Opioid rate vs peers
3.6% vs 2.6% avg
+63%
Cost per patient vs peers
$1,741 vs $1,068 avg
+34%
Brand preference vs peers
12.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.6%
Opioid Rate
358
Opioid Claims
$10K
Opioid Cost
10.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,207 claims · $1.0M
Generic: 8,777 claims · $294K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 99 | $180K |
| Empagliflozin | 70 | $113K |
| Apixaban | 58 | $81K |
| Liraglutide | 27 | $57K |
| Dapagliflozin Propanediol | 38 | $53K |
| Rivaroxaban | 35 | $53K |
| Semaglutide | 16 | $38K |
| Insulin Degludec | 14 | $37K |
| Sitagliptin Phosphate | 22 | $37K |
| Tirzepatide | 24 | $31K |
| Testosterone | 46 | $29K |
| Fluticasone/Umeclidin/Vilanter | 33 | $25K |
| Levothyroxine Sodium | 827 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 26 | $17K |
| Atorvastatin Calcium | 761 | $12K |
Prescribing Profile
Patient Profile
74
Avg Age
32%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About